SCHEMBL19554264

SCHEMBL19554264

Nc1cc(OCc2ccccc2)c(Cl)cc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 7/20 0.53
PTGER1 P34995 2/20 0.53
FOLH1 Q04609 1/20 0.51
HPGD P15428 4/20 0.50
MCL1 Q07820 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
RXRA P19793 1/20 0.50
RXRB P28702 1/20 0.50
CHRM4 P08173 1/20 0.50
CHRM3 P20309 1/20 0.50
CLCN2 P51788 1/20 0.50
MEN1 O00255 1/20 0.50
MITF O75030 1/20 0.50
TP53 P04637 1/20 0.50
XBP1 P17861 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9550355 0.89 FOLH1 (0.55) MRGPRX4PTGER1FOLH1HPGDMCL1
SCHEMBL383618 0.87 FOLH1 (0.58) MRGPRX4PTGER1FOLH1HPGDMCL1
SCHEMBL20535507 0.83 GAA (0.51) MRGPRX4HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL12659905 0.83 MCL1 (0.60) MRGPRX4PTGER1FOLH1HPGDMCL1
SCHEMBL16432058 0.83 FOLH1 (0.55) PTGER1FOLH1MCL1RAB9ASMN1; SMN2
SCHEMBL30261516 0.83 MRGPRX4 (0.60) MRGPRX4PTGER1FOLH1HPGDMCL1
SCHEMBL3138320 0.82 CTSV (0.57) MRGPRX4FOLH1HPGDNPC1RAB9A
SCHEMBL4728946 0.82 CTSV (0.57) MRGPRX4FOLH1HPGDNPC1RAB9A
SCHEMBL7797930 0.82 MRGPRX4 (0.61) MRGPRX4PTGER1FOLH1HPGDMCL1
SCHEMBL2565901 0.82 GAA (0.50) MRGPRX4HPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017192304-A1 ARYLCARBOXAMIDES AND USES THEREOF INCEPTION 1, INC. (US) 2017-11-09 WO disclosed